Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ATHE
Stock Latest News
The Fly
Alterity Therapeutics Ltd (ADR) trading halted, news pending
8h ago
ATHE
Premium
The Fly
Alterity Therapeutics reports cash balance of A$40.66M as of June 30
1M ago
ATHE
Premium
Ratings
Buy Rating for Alterity Therapeutics: Promising Phase 2 Results and Investment Opportunity Amid Stock Price Dip
1M ago
ATHE
Premium
The Fly
Alterity Therapeutics reports topline data from open-label Phase 2 ATH434 trial
1M ago
ATHE
Premium
The Fly
Alterity Therapeutics announces publication on MRI endpoint from bioMUSE study
1M ago
ATHE
Premium
Company Announcements
Alterity Therapeutics Announces Change in Substantial Holding
2M ago
6K
ATHE
Premium
Company Announcements
Alterity Therapeutics Announces Cessation of Securities Due to Unmet Conditions
2M ago
6K
ATHE
Premium
The Fly
Alterity Therapeutics has several presentations featured at 2025 MSA Congress
4M ago
ATHE
Premium
The Fly
Alterity Therapeutics has several presentations featured at 2025 MSA Congress
4M ago
ATHE
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
MRK
ATHE
Premium
The Fly
Alterity Therapeutics management to meet with Maxim
4M ago
ATHE
Premium
The Fly
Alterity Therapeutics granted U.S. FDA Fast Track designation for ATH434
4M ago
ATHE
Premium
Company Announcements
Alterity Therapeutics Reports Positive Phase 2 Trial Results for MSA Treatment
4M ago
6K
ATHE
Premium
The Fly
Alterity Therapeutics reports cash balance of A$17.96M as of March 31
4M ago
ATHE
Premium
Company Announcements
Alterity Therapeutics Announces Director Securities Changes
4M ago
6K
ATHE
Premium
The Fly
Alterity presents ATH434-201 Phase 2 trial results at MSA Symposium
4M ago
ATHE
Premium
Ratings
Promising Phase 2 Results and Technological Integration Justify Buy Rating for Alterity Therapeutics
5M ago
ATHE
Premium
The Fly
Alterity Therapeutics reports new data from ATH434 Phase 2 trial at AAN meeting
5M ago
ATHE
Premium
The Fly
Alterity Therapeutics completes last patient visit in ATH434-202 Phase 2 trial
5M ago
ATHE
Premium
Company Announcements
Alterity Therapeutics Completes Key Phase 2 Trial for MSA Treatment
5M ago
6K
ATHE
Premium
Company Announcements
Alterity Therapeutics Reports Progress and Financial Results
6M ago
ATHE
Premium
Ratings
Buy Rating for Alterity Therapeutics: Strong Financial Position and Promising Clinical Results
6M ago
ATHE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
